Susquehanna Portfolio Strategies’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-58,972
Closed -$833K 1086
2025
Q3
$833K Buy
58,972
+29,518
+100% +$460K 0.01% 717
2025
Q2
$566K Buy
+29,454
New +$460K 0.01% 624
2024
Q3
Sell
-13,648
Closed -$788K 455
2024
Q2
$788K Sell
13,648
-427
-3% -$20.9K 0.03% 314
2024
Q1
$469K Hold
14,075
0.01% 599
2023
Q4
$1.14M Buy
+14,075
New +$1.15M 0.02% 565

Other funds holding OM

Susquehanna Portfolio Strategies's OM Position: Q4 2025 in Review

Susquehanna Portfolio Strategies sold out of Outset Medical (OM) in Q4 2025, closing a stake of 58,972 shares — an estimated $833K sold.

Susquehanna Portfolio Strategies first reported a position in OM in Q4 2023 and held it in 5 quarters. The position peaked at $1.14M in Q4 2023. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Susquehanna Portfolio Strategies reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 58,972 Outset Medical shares in Q4 2025, an estimated $833K.
  • Susquehanna Portfolio Strategies first reported a position in Outset Medical in Q4 2023 and held it in 5 quarters.
  • Susquehanna Portfolio Strategies's Outset Medical position peaked at $1.14M in Q4 2023.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.